# Daiichi Sankyo Company Limited

Daiichi Sankyo's stock dips amid profit target concerns and market access hurdles. Social media buzz highlights advancements in oncology treatments and strategic partnerships.

### About Daiichi Sankyo Company Limited
Daiichi Sankyo Company Limited is a global pharmaceutical company focused on oncology.  

### Insights
- Daiichi Sankyo Company Limited mentions hit [--] which is 104% higher than it's daily average.
- Daiichi Sankyo Company Limited creators is up 22.22% from the previous week.
- Daiichi Sankyo Company Limited mentions is up 37.68% from the previous week.
- Daiichi Sankyo Company Limited Mentions hit a 52-Week high of [--] for the day

### Price: $
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$4568t/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$4568t/time-series/close.tsv)  
Daiichi Sankyo's stock fell 4.5% due to unchanged profit targets and pricing/market access challenges, compounded by potential tariffs on Japanese-made drugs. This is further supported by critical themes highlighting pricing and market access challenges.  

1-Year High: $4,174 on 2025-10-09  
1-Year Low: $2,836 on 2026-01-30  
  
  
### AltRank: [---]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$4568t/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$4568t/time-series/alt_rank.tsv)  
Daiichi Sankyo Company Limited is currently AltRank #963 based on combined combined social and market metrics
Daily Average: [---]  
1-Year High: [-----] on 2025-03-10  
1-Year Low: [---] on 2025-12-25  
  
  
### Galaxy Score: [--]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$4568t/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$4568t/time-series/galaxy_score.tsv)  
Current Value: [--]  
Daily Average: [--]  
1-Year High: [--] on 2025-02-25  
1-Year Low: [--] on 2025-07-21  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$4568t/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$4568t/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [------]  
[--] Week: [-----] -97%  
[--] Month: [-------] +632%  
[--] Months: [-------] -96%  
[--] Year: [----------] -51%  
1-Year High: [---------] on 2025-03-31  
1-Year Low: [--] on 2025-11-09  

Engagements by network (24h):
Instagram: [--]
YouTube: [--]
X: [-----]
TikTok: [--]
News: [--]
Reddit: [--]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$4568t/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$4568t/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [--] +38%  
[--] Month: [---] +18%  
[--] Months: [---] +16%  
[--] Year: [-----] +111%  
1-Year High: [--] on 2026-02-12  
1-Year Low: [--] on 2025-03-08  

Mentions by network (24h):
Instagram: [--]
YouTube: [--]
X: [--]
TikTok: [--]
News: [--]
Reddit: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$4568t/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$4568t/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Daiichi Sankyo Company Limited in the last [--] hours which is up 13% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [--] +22%  
[--] Month: [---] -5.90%  
[--] Months: [---] +14%  
[--] Year: [---] +101%  
1-Year High: [--] on 2025-12-18  
1-Year Low: [--] on 2025-08-10  

The most influential creators that mention Daiichi Sankyo Company Limited in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@unseenvalue](/creator/twitter/unseenvalue)         | [--]    | [-------]   | [--]     | [-----]       |
| [@DaiichiSankyoES](/creator/twitter/DaiichiSankyoES) | [--]    | [-----]     | [--]    | [---]         |
| [@DaiichiSankyoUS](/creator/twitter/DaiichiSankyoUS) | [--]    | [-----]     | [--]     | [--]          |
| [@stellanewslife](/creator/twitter/stellanewslife)   | [--]    | [-----]     | [--]     | [--]          |
| [@H2AK119ub](/creator/reddit/H2AK119ub)              | [--]    | [------]    | [--]     | [--]           |

[View More](/list/creators/$4568t/100)
  
  
### Sentiment: 92%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$4568t/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$4568t/time-series/sentiment.tsv)  
Current Value: 92%  
Daily Average: 84%  
[--] Week: 88% +8%  
[--] Month: 88% +15%  
[--] Months: 88% -6%  
[--] Year: 88% -12%  
1-Year High: 100% on 2025-02-17  
1-Year Low: 36% on 2025-05-22  

Most Supportive Themes:
- Oncology Pipeline Advancement: (40%) Daiichi Sankyo is making significant strides in its oncology pipeline, particularly with its antibody-drug conjugate (ADC) technology, leading to promising trial results and regulatory advancements.
- Strategic Partnerships and Collaborations: (30%) The company is actively engaging in strategic partnerships, notably with AstraZeneca, to co-develop and commercialize innovative cancer treatments, enhancing its market position and R&D capabilities.
- Market Expansion and Product Launches: (20%) Daiichi Sankyo is focused on expanding its market reach through new product launches and label expansions, as seen with Enhertu, indicating a strong commercial strategy and growing product portfolio.
  
Most Critical Themes:
- Pricing and Market Access Challenges: (70%) Despite promising trial data, Daiichi Sankyo faces challenges related to pricing and market access for its key drugs, as highlighted by the NICE decision regarding Enhertu, which could impact adoption rates.
- Competition in the Oncology Space: (30%) The oncology market is highly competitive, with numerous companies vying for market share. Daiichi Sankyo's success depends on maintaining its innovative edge and effectively differentiating its treatments.
  
  
  
### Market Cap: $undefined
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$4568t/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$4568t/time-series/market_cap.tsv)  
Current Value: $undefined  
Daily Average: $6,738,880,366,548  
1-Year High: $7,065,992,123,959 on 2025-03-27  
1-Year Low: $6,460,929,913,719 on 2025-02-20  

### Top Daiichi Sankyo Company Limited Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"Enhertu ADC Drug Linker Japanese Innovator 📸1: Combined sales of Enhertu recorded by Daiichi Sankyo and AstraZeneca amounted to $4982m in FY [----] (FY 2024: $3754m) 📸2: ➡Over the years we have strengthened our expertise in high-potency APIs ADC molecules sterile injectables and complex chemistry ➡Landmark co-investment agreement with a Japanese innovator to expand ADC linker capacity in Switzerland (Ref: Dishman Carbogen) https://twitter.com/i/web/status/2022898952782385588 https://twitter.com/i/web/status/2022898952782385588"  
[X Link](https://x.com/punitbansal14/status/2022898952782385588) [@punitbansal14](/creator/x/punitbansal14) 2026-02-15T05:01Z 30.7K followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing